| abstract |
The invention provides an agent that activates stem cells and / or progenitor cells, including batroxobin, which can be used in regenerative medicine, and especially in regenerative medicine using self-regeneration, acting quickly and moderately depending on the extent and degree of damage to organs and / or tissues, to which regenerative medicine is applied, with minor side effects or without them. The present invention also provides a method for activating stem cells and / or progenitor cells in an animal, comprising the step of administering to the animal an effective amount of batroxobin and using batroxobin to activate stem cells and / or progenitor cells. |